Article

Alpha-synuclein overexpression can drive microbiome dysbiosis in mice

2024-02-01

Abstract excerpt

<h4>ABSTRACT</h4> Growing evidence indicates that persons living with Parkinson disease (PD), have a unique composition of indigenous gut microbes. Given the long prodromal or pre-diagnosed period, longitudinal studies of the human and rodent gut microbiome prior to symptomatic onset and for the duration of the disease period are currently lacking. PD is characterized in part by accumulation of the protein α-synu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 25ff0433-6624-5c14-baeb-d35ca3f05f0c
DOI: 10.1101/2024.02.01.578464

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Alpha-synuclein overexpression can drive microbiome dysbiosis in miceDOI 10.1101/2024.02.01.578464Read

Alpha synuclein overexpression can drive microbiome dysbiosis in miceSemantic proximity Read

Functional Metagenomic Analysis Reveals Early Gut Microbiota Alterations in Alpha-Synuclein Transgenic Mice: Insights into Parkinson’s Disease ProgressionSemantic proximity Read

Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson diseaseSemantic proximity Read

Exploring human-genome gut-microbiome interaction in Parkinson’s diseaseSemantic proximity Read

A microbiome quantitative trait locus in SLC39A8 modulates disease severity in synucleinopathy-induced models of Parkinson's disease.Semantic proximity Read

Human-genome gut-microbiome interaction in Parkinson’s diseaseSemantic proximity Read

α-synuclein overexpression and the microbiome shape the gut and brain metabolome in miceSemantic proximity Read

α-Synuclein Overexpression and the Microbiome Shape the Gut and Brain Metabolome in MiceSemantic proximity Read

Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PDSemantic proximity Read

Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson’s diseaseSemantic proximity Read

Mechanistic insights into accelerated α-synuclein aggregation mediated by human microbiome-associated functional amyloidsSemantic proximity Read

Elucidating the dysbiotic features of gut microbiome, interaction with the human genome, and utility as a biomarker for treatment of Parkinson’s diseaseSemantic proximity Read